BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Begum M ET, Sen D. DOR agonist (SNC-80) exhibits anti-parkinsonian effect via downregulating UPR/oxidative stress signals and inflammatory response in vivo. Neurosci Lett 2018;678:29-36. [PMID: 29727730 DOI: 10.1016/j.neulet.2018.04.055] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Voronin MV, Abramova EV, Verbovaya ER, Vakhitova YV, Seredenin SB. Chaperone-Dependent Mechanisms as a Pharmacological Target for Neuroprotection. Int J Mol Sci 2023;24. [PMID: 36614266 DOI: 10.3390/ijms24010823] [Reference Citation Analysis]
2 Lin MM, Liu N, Qin ZH, Wang Y. Mitochondrial-derived damage-associated molecular patterns amplify neuroinflammation in neurodegenerative diseases. Acta Pharmacol Sin 2022. [PMID: 35233090 DOI: 10.1038/s41401-022-00879-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
3 Xu Y, Chen R, Zhi F, Sheng S, Khiati L, Yang Y, Peng Y, Xia Y. δ-opioid Receptor, Microglia and Neuroinflammation. Aging and disease 2022. [DOI: 10.14336/ad.2022.0912] [Reference Citation Analysis]
4 Wang Y, Gao L, Chen J, Li Q, Huo L, Wang Y, Wang H, Du J. Pharmacological Modulation of Nrf2/HO-1 Signaling Pathway as a Therapeutic Target of Parkinson's Disease. Front Pharmacol 2021;12:757161. [PMID: 34887759 DOI: 10.3389/fphar.2021.757161] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
5 Xu Y, Zhi F, Mao J, Peng Y, Shao N, Balboni G, Yang Y, Xia Y. δ-opioid receptor activation protects against Parkinson's disease-related mitochondrial dysfunction by enhancing PINK1/Parkin-dependent mitophagy. Aging (Albany NY) 2020;12:25035-59. [PMID: 33197884 DOI: 10.18632/aging.103970] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
6 Bodnar RJ. Endogenous Opiates and Behavior: 2018. Peptides 2020;132:170348. [PMID: 32574695 DOI: 10.1016/j.peptides.2020.170348] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
7 Ferreira C, Almeida C, Tenreiro S, Quintas A. Neuroprotection or Neurotoxicity of Illicit Drugs on Parkinson's Disease. Life (Basel) 2020;10:E86. [PMID: 32545328 DOI: 10.3390/life10060086] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
8 Mullick M, Banerjee S, Sen D. Amelioration of Acetaminophen-Induced Liver Injury Via Delta Opioid Receptor–Activated Human Mesenchymal Stem Cells—an In Vivo Approach. Regen Eng Transl Med 2019;5:263-269. [DOI: 10.1007/s40883-019-00101-w] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Intlekofer KA, Clements K, Woods H, Adams H, Suvorov A, Petersen SL. Progesterone receptor membrane component 1 inhibits tumor necrosis factor alpha induction of gene expression in neural cells. PLoS One 2019;14:e0215389. [PMID: 31026287 DOI: 10.1371/journal.pone.0215389] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
10 Thanjeem Begum ME, Baul HS, Venkatesh K, Sen D. Novel miRNA expression in the delta opioid signaling pathway mediated cell survivability in an in vitro model of ER stress. Nanomedicine 2019;17:150-87. [PMID: 30716419 DOI: 10.1016/j.nano.2019.01.009] [Reference Citation Analysis]